![News Logos15 News Logos15](https://usbiologic.com/wp-content/uploads/2021/12/News-Logos15-300x188.jpg)
Long-underfunded Lyme disease research gets an injection of money—and ideas
Months after a U.S. Congress–mandated working group sounded the alarm about tickborne illnesses and urged more federal action and money, the National Institutes of Health (NIH) is readying a strategic plan for these diseases. Last week it also, serendipitously, issued a rare solicitation for prevention proposals in tickborne diseases. The new pot of money, $6 million in 2020, represents a significant boost; NIH spent $23 million last year on Lyme disease, by far the most common tickborne illness, within $56 million devoted to tickborne diseases overall.